Impact of E-Cigarette Use on Cardiovascular Disease Risk

Study Overview

A recent study published in the journal Circulation, by the American Heart & Stroke Foundation, has indicated that e-cigarette use does not significantly affect the risk of cardiovascular disease (CVD). The research specifically examined individuals who engage in “dual use”—those who use both conventional cigarettes and e-cigarettes—and found their CVD risk to be comparable to that of exclusive combustible cigarette smokers.

Are E-Cigarettes Harmful?

E-cigarettes have surged in popularity, often marketed as a “healthier” alternative to traditional smoking. However, existing research challenges this notion. E-cigarettes may contain harmful substances such as nicotine, metals, fine particulate matter, and various organic compounds. One study highlighted that e-cigarette consumption can provoke inflammation and oxidative stress, potentially leading to tissue damage. A critical question remains: Do e-cigarettes, similar to conventional cigarettes, heighten CVD risk?

Study Methodology

The research team from Boston University analyzed data from the Population Assessment of Tobacco and Health (PATH) study, which collected annual surveys from participants in the U.S. between 2013 and 2019. A total of 324,027 individuals aged 18 and older were eligible, with 51% being women and 50% under 35 years old. Participants were categorized into groups: sole conventional cigarette users, sole e-cigarette users, dual users, and non-users, based on specific smoking criteria.

Findings on CVD Risk

During annual check-ups, participants self-reported their smoking habits and were screened for cardiovascular disease. Throughout the study, 1,487 CVD cases were identified. The researchers determined that participants who exclusively used e-cigarettes did not have a higher likelihood of developing CVD when compared to non-users. Furthermore, dual users showed no significant difference in CVD risk when compared to those who only smoked conventional cigarettes. Co-author Andrew C. Stokes remarked, “Many smokers who attempt to use e-cigarettes for traditional cigarette smoking cessation actually continue using both products, becoming dual users, where we saw no reduction in cardiovascular risk.”

Future Research Directions

Although the total sample size was 324,027, the authors noted that increasing the sample could enhance the reliability of the findings. Among sole e-cigarette users, only 41 developed CVD, while 113 dual users did. A larger cohort might provide more conclusive evidence. Additionally, prolonged monitoring of individuals may yield more accurate results, as the authors acknowledged that CVD can develop progressively, necessitating long-term observation.

References

1. Berlowitz, J.B. et al. (2022). E-cigarette Use and Risk of Cardiovascular Disease: A Longitudinal Analysis of the PATH Study, 2013-2019. Circulation; 145: 00-00. Doi: 10.1161/CIRCULATIONAHA.121.057369.
2. Tarran, R. et al. (2021). E-cigarettes and cardiopulmonary health. Function;11: zqab004. doi: 10.1093/FUNCTION/ZQAB004.
3. National Addiction & HIV Data Archive Program. (2021). Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files. University of Michigan. Doi: 10.3886/ICPSR36498.v16.
4. Lewis, C. (2022). No health benefits among adults who used both e-cigarettes and traditional cigarettes. EurekAlert! Accessed May 9, 2022. Retrieved from https://www.eurekalert.org/news-releases/951601.
5. Photo by Luan Rezende from Pexels.